🇰🇷 South Korea Country × Condition
advanced solid tumor Clinical Trials in South Korea
Active clinical trials for advanced solid tumor with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT07128303 Phase 1
Recruiting
Study of GS-5319 in Adults With Solid Tumors
Enrollment
178 pts
Country
🇰🇷 South Korea
Gilead Sciences
View Trial → NCT05768932 Phase 1
Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Enrollment
260 pts
Country
🇰🇷 South Korea
SillaJen, Inc.
View Trial → Frequently Asked Questions
How many advanced solid tumor clinical trials are active in South Korea?
There are currently 2 active clinical trials for advanced solid tumor with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a advanced solid tumor clinical trial in South Korea?
To join a advanced solid tumor clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are advanced solid tumor trials in South Korea?
Active advanced solid tumor trials in South Korea span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology